The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: A randomized controlled trial

Journal of Clinical Pharmacology

Volumn 52, Issue 9, 2012, Pages 1365-1372

  Fraga, Cassiana Mazon ^a,b   Tomasi, Cristiane Damiani ^a   Biff, Daiane ^a   Topanotti, Maria Fernanda Locks ^a   Felisberto, Francine ^a   Vuolo, Francieli ^a   Petronilho, Fabricia ^a   Dal Pizzol, Felipe ^a,b   Ritter, Cristiane ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b HOSPITAL SÃO JOSÉ   (Brazil)

Author keywords

antioxidants; hypotension; Renal failure; shock

Indexed keywords

ACETYLCYSTEINE; CREATININE; CYTOKINE; DEFEROXAMINE; INTERLEUKIN 6; PLACEBO; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOTENSION; INFLAMMATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; ADULT; AGED; ANTIOXIDANTS; CRITICAL ILLNESS; DEFEROXAMINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOTENSION; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRITES; OXIDATIVE STRESS; SIDEROPHORES;

EID: 84866039322     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270011418657     Document Type: Article

References (36)

1. Hoste EAJ, Schurgers M. Epidemiology of acute kidney injury: how big is the problem?. Crit Care Med. 2008 ; 36: S146 - S151
2. Kellum JA. Acute kidney injury. Crit Care Med. 2008 ; 36: S141 - S145
3. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006 ; 10: R73
4. Cruz DN, Bolgan I, Perazella MA, et al. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE criteria. Clin J Am Soc Nephrol. 2007 ; 2: 418-425
5. Uchino S, Kellun JA, Bellomo R, et al. Acute renal failure in critically ill patients. JAMA. 2005 ; 294: 813-818
6. Maccariello E, Soares M, Valente C, et al. RIFLE classification in patients with acute kidney injury in need of renal replacement therapy. Intensive Care Med. 2007 ; 33: 597-605
7. Komisarof JA, Gilkey GM, Peters DM, et al. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure. Crit Care Med. 2007 ; 35: 435-441
8. Laurent B, Ardaillou R. Reative oxygen species: production and role in the kidney. Am J Physiol. 1986 ; 251: F765 - F776
9. Ueda N, Shah S. Endonuclease induced damage and cell death in oxidant injury to renal tubular epithelial cells. J Clin Invest. 1992 ; 90: 2593-2597
10. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad the ugly. Am J Physiol. 1996 ; 271: C1424 - C1437
11. McCord J. Oxygen derived free radicals in postischemic tissue injury. N Engl J Med. 1985 ; 312: 159-163
12. Takada M, Nadeau KC, Shaw GD, et al. The cytokine adhesion molecule cascade on ischemia/reperfusion injury of the rat kidney: inhibition by a soluble P selectin ligand. J Clin Invest. 1999 ; 99: 2682-2690
13. Rabb H, O'Meara YM, Maderna P, et al. Leucocytes, cell adhesion molecules and ischemic renal failure. Kidney Int. 1997 ; 51: 1463-1468
14. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-acetylcysteine: a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007 ; 7: 355-359
15. Spapen HD, Diltoer MW, Nguyen DN, et al. Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis. Chest. 205 ; 127: 1413-1419
16. Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast induced nephropathy. Ann Intern Med. 2008 ; 148: 284-294
17. Duong MH, Mackenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv. 2005 ; 64: 471-479
18. Barichello T, Machado RA, Constantino L, et al. Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med. 2007 ; 35: 2186-2190
19. Sprong RC, Winkelhuyzen-Janssen ML, Aarman CJM, et al. Low dose N-acetylcysteine protects rats against endotoxin mediated oxidative stress, but high dose increase mortality. Am J Respir Crit Care Med. 1998 ; 157: 1283-1293
20. Burns KEA, Chu MWA, Novick RJ, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high risk patients undergoing CABG surgery: a randomized controlled trial. JAMA. 2005 ; 294: 342-350
21. Peake SL, Szakmany T, Heil P. N-acetylcysteine depresses cardiac performance in patients with septic shock. Crit Care Med. 1996 ; 29: 391-395
22. Ritter C, Andrades M, Moreira JCF, et al. Antioxidants and sepsis: can we find the ideal approach?. Crit Care Med. 2004 ; 32: 1445-1446
23. Ritter C, Cunha AA, Echer IC, et al. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med. 2006 ; 34: 471-477
24. Ritter C, Andrades ME, Reinke A, et al. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med. 2004 ; 32: 342-349
25. Petronilho F, Constantino L, Souza B, et al. Efficacy of the combination of N- acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male wistar rats. Nephrol Dial Transplant. 2009 ; 24: 2077-2082
26. Zyoud SH, Awang R, Sulaiman SA, Al-Jabi SW. Effects of delay in infusion of N-acetylcysteine on appearance of adverse drug reactions after acetaminophen overdose: a retrospective study. Pharmacoepidemiol Drug Saf. 2010 ; 19: 1064-1070
27. Somech R, Seaban-Adel K, Atkinson A, Kirby-Allen M. Evaluation and management of pediatric patients with anaphylactoid reactions to deferoxamine mesylate. Ann Allergy Asthma Immunol. 2007 ; 99: 575-576
28. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990 ; 186: 421-431
29. Levine RL, Garland D, Oliver CN. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990 ; 186: 464-478
30. Green IC, Wagner DA, Glowski J, Skipper PL, Wishnok IS, Tannenbaum SB. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem. 1982 ; 126: 131-138
31. Sajewicz W. Effect of thiol drugs on tert-butyl hydroperoxide induced luminol chemiluminescence in human erythrocytes, erythrocyte lysate, and erythrocyte membranes. Chem Biol Interact. 2010 ; 186: 144-151
32. Sagrista ML, Garcia AF, Madariaga MA, et al. Antioxidant and pro oxidant effect of the thiolic compounds N-acetyl-L-cysteine and glutathione against free radical induced lipid peroxidation. Free Radic Res. 2002 ; 36: 329-340
33. Buculu F, Oktenli C, Kenar L, et al. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with adriamycin induced nephritic syndrome. J Nephrol. 2008 ; 21: 576-583
34. Hoffmann U, Fischereder M, Kruger B, et al. The value of N-acetylcysteine in the prevention of radiocontrast agent induced nephropathy seems questionable. J Am Soc Nephrol. 2004 ; 15: 407-410
35. Haase M, Haase-Fielitz A, Ratnaike S, et al. N-acetylcysteine does not artifactually lower plasma creatinine concentration. Nephrol Dial Transplant. 2008 ; 23: 1581-1587
36. Peake SL, Moran JL, Leppard PI. N-acetylcysteine depresses cardiac performance in patients with septic shock. Crit Care Med. 1996 ; 24: 1302-1310